Stocks to Watch: Lululemon, Lava Therapeutics, Tilly's, Oncorus
2023年6月2日 - 8:38AM
Dow Jones News
By Sabela Ojea
Lululemon Athletica on Thursday raised its outlook for the year
amid significant sales growth in China. Shares of the athletic-gear
maker climbed 13%, to $371.67, in after-hours trading.
Lava Therapeutics on Thursday said a lead candidate aimed at an
undisclosed tumor-associated antigen was selected for further
development toward clinical studies by Janssen Biotech. Shares of
the biotechnology company surged 26%, to $2.40, in after-hours
trading.
Tilly's guided for wider-than-expected losses in the fiscal
second quarter. Shares of the clothing retailer dropped 13%, to
$6.41, in after-hours trading.
Oncorus said it plans to cut nearly its entire workforce and
anticipates its finances won't meet its needs beyond the third
quarter. Shares of the biotechnology company plunged 24%, to 14
cents, in after-hours trading.
Write to Sabela Ojea at sabela.ojea@wsj.com
(END) Dow Jones Newswires
June 01, 2023 19:23 ET (23:23 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
LAVA Therapeutics NV (NASDAQ:LVTX)
過去 株価チャート
から 4 2024 まで 5 2024
LAVA Therapeutics NV (NASDAQ:LVTX)
過去 株価チャート
から 5 2023 まで 5 2024